Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation

scientific article published on 01 December 2000

Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11154118

P50authorHeikki RauvalaQ38644081
P2093author name stringImai S
Parkkinen J
Rouhiainen A
P433issue6
P304page(s)1087-1094
P577publication date2000-12-01
P1433published inThrombosis and HaemostasisQ15724413
P1476titleOccurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation
P478volume84

Reverse relations

cites work (P2860)
Q33358039A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes
Q48732970ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury
Q33676193Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET
Q64092947Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
Q26744644Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases
Q42355573Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice
Q35953553HMGB1 is a therapeutic target for sterile inflammation and infection
Q28577024High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues
Q41952666High mobility group box 1 protein induction by Mycobacterium bovis BCG.
Q28118997High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine
Q37206315High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
Q21034098Human malarial disease: a consequence of inflammatory cytokine release
Q35971929Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction.
Q90647008Inhibition of Homophilic Interactions and Ligand Binding of the Receptor for Advanced Glycation End Products by Heparin and Heparin-Related Carbohydrate Structures
Q37457072Innate immunity, coagulation and placenta-related adverse pregnancy outcomes
Q28078773Intercellular Interactions as Regulators of NETosis
Q27023542Ménage à Trois in stress: DAMPs, redox and autophagy
Q34334123New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal
Q35838590Pathogenesis of malaria and clinically similar conditions
Q47118391Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke
Q88123532Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice
Q38362628Platelet transfusion - the new immunology of an old therapy
Q36335907Platelet-derived HMGB1 is a critical mediator of thrombosis.
Q42155026Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes
Q38542454Platelets and Their Interactions with Other Immune Cells
Q48136773Platelets at the crossroads of thrombosis, inflammation and haemolysis.
Q26741571Platelets: New Bricks in the Building of Neutrophil Extracellular Traps
Q47220872Post-translational modifications of high mobility group box 1 and cancer
Q35922965RETRACTED ARTICLE: HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms
Q38682450Regulation of Posttranslational Modifications of HMGB1 During Immune Responses
Q35610210Role of HMGB1 in cardiovascular diseases
Q41836991Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes.
Q41967145Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products
Q91819199Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
Q35108949The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers
Q38195181The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo
Q33732343The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis
Q27010599The translocation of nuclear molecules during inflammation and cell death
Q38103542Transfusion-Related Acute Lung Injury: The Work of DAMPs.
Q37421806Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.
Q47153310Trypsinogen Activation Peptide Induces HMGB1 Release from Rat Pancreatic Acinar Cells
Q26749091Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis

Search more.